Primary Record
Idetrexed
- In stock
- 9,017 g
- Purity
- 98.8 %
- CAS
- 501332-69-0
Compound Identifiers & Properties
- CAS
- 501332-69-0
- PubChem CID
- 135487419
- SMILES
- C#CCN([C@H]1CCC2=CC3=C(C=C12)C(=O)NC(=N3)CO)C4=CC=C(C=C4)C(=O)N[C@@H](CCC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O
- Canonical SMILES
- C#CCN(c1ccc(C(=O)N[C@@H](CCC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O)cc1)[C@H]1CCc2cc3nc(CO)[nH]c(=O)c3cc21
Names & Synonyms
- Idetrexed
- BGC 945
- BGC-945
- BGC945
- IDETREXED [INN]
- ONX-0801
- RefChem:917127
- Q718FS1C7X
- ONX 0801
- IDETREXED [WHO-DD]
- ONX-801
- 501332-69-0
- 6S-BGC-945
- UNII-Q718FS1C7X
- DTXSID701337116
- GTPL9590
- CHEMBL4594449
- SCHEMBL10067675
- SCHEMBL29376379
- CHEBI:190251
- NVHRBQOZEMFKLD-CUYJMHBOSA-N
- DTXCID101767462
- CB-300945 (S)
- EX-A12280
- CID 11671880
- AKOS027461093
- CID11671880
- Silane,trimethyl[(methyltelluro)ethynyl]
- DA-64371
- HY-10822
- SID:53788450
- CB 300945 (S)
- CID:135487419
- CS-0002842
- J2.227.757J
- C21279
- C504662
- N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-Gamma-Glutamyl-D-Glutamic Acid
- Q27452165
- (2R)-2-[[(4S)-4-carboxy-4-[[4-[[(6S)-2-(hydroxymethyl)-4-oxo-1,6,7,8-tetrahydrocyclopenta[g]quinazolin-6-yl]-prop-2-ynylamino]benzoyl]amino]butanoyl]amino]pentanedioic acid
- (2R)-2-[[(4S)-4-carboxy-4-[[4-[[(6S)-2-(hydroxymethyl)-4-oxo-3,6,7,8-tetrahydrocyclopenta[g]quinazolin-6-yl]-prop-2-ynylamino]benzoyl]amino]butanoyl]amino]pentanedioic acid
- alpha-Folate Receptor-targeting Thymidylate Synthase Inhibitor ONX-0801
- N-(4-(2-propyn-1-yl(4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta(g)quinazolin-6-yl)amino)benzoyl)-l-gamma-glutamyl-d-glutamic acid
- (2R)-2-(((4S)-4-carboxy-4-((4-(((6S)-2-(hydroxymethyl)-4-oxo-1,6,7,8-tetrahydrocyclopenta(g)quinazolin-6-yl)-prop-2-ynylamino)benzoyl)amino)butanoyl)amino)pentanedioic acid
- (2R)-2-[(4S)-4-carboxy-4-[(4-{[(6S)-2-(hydroxymethyl)-4-oxo-3H,4H,6H,7H,8H-cyclopenta[g]quinazolin-6-yl](prop-2-yn-1-yl)amino}phenyl)formamido]butanamido]pentanedioic acid
- (6S)-6-[2-Propynyl[4-[[(1S)-4-[[(R)-1,3-dicarboxypropyl]amino]-1-carboxy-4-oxobutyl]carbamoyl]phenyl]amino]-2-(hydroxymethyl)-7,8-dihydro-6H-cyclopenta[g]quinazoline-4(3H)-one
- (R)-2-((S)-4-carboxy-4-(4-(((S)-2-(hydroxymethyl)-4-oxo-4,6,7,8-tetrahydro-3H-cyclopenta[g]quinazolin-6-yl)(prop-2-yn-1-yl)amino)benzamido)butanamido)pentanedioic acid
- 1JY
- D-GLUTAMIC ACID, N-(4-(2-PROPYNYL((6S)-4,6,7,8-TETRAHYDRO-2-(HYDROXYMETHYL)-4-OXO-1H-CYCLOPENTA(G)QUINAZOLIN-6-YL)AMINO)BENZOYL)-L-.GAMMA.-GLUTAMYL-
- D-Glutamic acid,N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benz
- L-|A-Glutamyl-N-(4-{[(6S)-2-(hydroxymethyl)-4-oxo-4,6,7,8-tetrahyd ro-1H-cyclopenta[g]quinazolin-6-yl](2-propyn-1-yl)amino}benzoyl)- D-glutamic acid
- N-(4-(2-PROPYN-1-YL((6S)-4,6,7,8-TETRAHYDRO-2-(HYDROXYMETHYL)-4-OXO-3H-CYCLOPENTA(G)QUINAZOLIN-6-YL)AMINO)BENZOYL)-L-.GAMMA.-GLUTAMYL-D-GLUTAMIC ACID
- N-(4-(2-Propyn-1-yl((6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta(g)quinazolin-6-yl)amino)benzoyl)-l-gamma-glutamyl-d-glutamic Acid
- N-(4-(2-propyn-1-yl(4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta(g)quinazolin-6-yl)amino)benzoyl)-gamma-glutamylglutamic acid
- N-[4-[2-Propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-gamma-glutamyl-d-glutamic acid 1